Safe Drinking Water Act Overview - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

Safe Drinking Water Act Overview

Description:

Group B1--Probable human carcinogen, limited human epi data ... Group C--Possible carcinogen--no human and limited animal data. Group D--Unclassifiable ... – PowerPoint PPT presentation

Number of Views:420
Avg rating:3.0/5.0
Slides: 14
Provided by: Barry137
Category:

less

Transcript and Presenter's Notes

Title: Safe Drinking Water Act Overview


1
Safe Drinking Water Act Overview
  • Environmental Law 2
  • Spring 2005

2
Mapping the Act
  • Major program areas--drinking water
    standard-setting
  • Regulatory instruments--command-and-control with
    disclosure

3
Key Distinctions 1
  • Large vs. small systems
  • Cost-benefit vs. other ways of dealing with cost
  • MCLGs vs MCLs

4
Underlying cost problems
  • Cost increases supralinear, benefits gains
    sublinear
  • Economies of scale (e.g., GAC)
  • Time spread--costs are now, benefits are (much)
    later
  • Cost increases are lumpy (e.g., GAC filtration)
  • SDWA drives Superfund cleanups (MCLGs)

5
Standard-Setting
  • Risk Assessment--MCLGs
  • NOAEL adequate margin of safety
  • What would it be if we didnt have to worry
    about cost?
  • Risk Management--MCLs
  • Feasibility Analysis--Best available technology
    taking cost into consideration
  • Originally gave variances and exceptions for
    small systems

6
The Escalation of CBATrihalomethanes (late 70s)
  • Student publication EPA should mandate high-cost
    treatment
  • White House CWPS CBA indicates small system
    deregulation
  • EPA CBA marginal benefit analysis justifies
    the rule w/ small system exceptions

7
EPA Policy Zero MCLG for Known or Probable
Carcinogens
  • Group A--Known Human Carcinogen
  • Group B1--Probable human carcinogen, limited
    human epi data
  • Group B2--Probable human carcinogen inadequate
    human, adequate animal data
  • Group C--Possible carcinogen--no human and
    limited animal data
  • Group D--Unclassifiable
  • Group E--No evidence of carcinogenicity, tests
    are adequate

8
Is cancer really a no-threshold toxin?Bruce
Ames says Maybe not
International Fabricare Institute, 972 F.2d 384
(1992)
9
EPA Policy GAC Filtration Is a Feasible
Technology for Synthetic Organic Chemicals
  • Pentachlorphenol example
  • In a system serving 62,000 people, save 1 life in
    1,650 years at a cost of 860m
  • In a system serving 250 people, save one life in
    500,000 years, at a cost of 5.4 billion

10
Political imperatives
  • Environmental community opposes CBA, exemptions
    for small systems
  • Small systems could not afford GAC filtration,
    even if the federal government gave them the
    plants
  • Proliferating MCLs make testing and reporting
    costly, difficult
  • Unfunded mandates and small business impacts make
    regulation difficult
  • Health scares focus public attention on drinking
    water

11
A Great Lakes problem if we limit diversions, we
may increase health risks
12
A general problemHow do you do a cost-benefit
analysis for something that isnt dose-dependent
(the hormone mimics)
13
Another general problemHow do you deal with
especially sensitive populations?
  • EPA must consider The effects of the
    contaminant on the general population and on
    groups within the general populations such as
    infants, children, pregnant women, the elderly,
    individuals with a history of serious illness, or
    other subpopulations that are identified as
    likely to be at greater risk of adverse health
    effects due to exposure to contaminants in
    drinking water than the general population.
Write a Comment
User Comments (0)
About PowerShow.com